Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Vitamin plasma concentration

Potischman, N. et al.. Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A, Am. J. Clin. Nutr, 52, 909, 1990. [Pg.141]

Lequea et al. used the activity of tyrosine apodecarboxylase to determine the concentration of the enzyme cofactor pyridoxal 5 -phosphate (vitamin B6). The inactive apoenzyme is converted to the active enzyme by pyridoxal 5 -phosphate. By keeping the cofactor the limiting reagent in the reaction by adding excess apoenzyme and substrate, the enzyme activity is a direct measure of cofactor concentration. The enzymatic reaction was followed by detecting tyramine formation by LCEC. The authors used this method to determine vitamin B6 concentrations in plasma samples. [Pg.29]

Kayden, H.J. andTraber, M.G. (1993). Absorption, lipoprotein transport and regulation of plasma concentrations of vitamin E in humans. J. Lipid Res. 34, 343-358. [Pg.35]

Riso, P, F Visioli, D Erba, G Testolin, and M Porrini. 2004. Lycopene and vitamin C concentrations increase in plasma and lymphocytes after tomato intake. Effects on cellular antioxidant protection. Eur J Clin Nutr 58 1350-1358. [Pg.463]

There seems to be no metabolic control exerted on hepatic 25-hydroxylase and so all of the available cholecalciferol is converted. Hydroxylation in the kidney however is an important control point being regulated by PTH, and indirectly therefore by calcium and phosphate concentrations. Stimulation of la-hydroxylase by PTH is via a cyclic AMP (cAMP) -dependent mechanism and longer-term regulation of the activity of this enzyme is via induction mediated by other hormones such as oestrogens, cortisol and growth hormone. Typically, the plasma concentration of 1,25 dihydroxy vitamin D is in the range 20-60 ng/1, that is approximately 1000-times lower than that of its precursor. [Pg.300]

Figure 22.6 How various factors increase the risk of atherosclerosis, thrombosis and myocardial infarction. The diagram provides suggestions as to how various factors increase the risk of development of the trio of cardiovascular problems. The factors include an excessive intake of total fat, which increases activity of clotting factors, especially factor VIII an excessive intake of saturated or trans fatty acids that change the structure of the plasma membrane of cells, such as endothelial cells, which increases the risk of platelet aggregation or susceptibility of the membrane to injury excessive intake of salt - which increases blood pressure, as does smoking and low physical activity a high intake of fat or cholesterol or a low intake of antioxidants, vitamin 6 2 and folic acid, which can lead either to direct chemical damage (e.g. oxidation) to the structure of LDL or an increase in the serum level of LDL, which also increases the risk of chemical damage to LDL. A low intake of folate and vitamin B12 also decreases metabolism of homocysteine, so that the plasma concentration increases, which can damage the endothelial membrane due to formation of thiolactone. Figure 22.6 How various factors increase the risk of atherosclerosis, thrombosis and myocardial infarction. The diagram provides suggestions as to how various factors increase the risk of development of the trio of cardiovascular problems. The factors include an excessive intake of total fat, which increases activity of clotting factors, especially factor VIII an excessive intake of saturated or trans fatty acids that change the structure of the plasma membrane of cells, such as endothelial cells, which increases the risk of platelet aggregation or susceptibility of the membrane to injury excessive intake of salt - which increases blood pressure, as does smoking and low physical activity a high intake of fat or cholesterol or a low intake of antioxidants, vitamin 6 2 and folic acid, which can lead either to direct chemical damage (e.g. oxidation) to the structure of LDL or an increase in the serum level of LDL, which also increases the risk of chemical damage to LDL. A low intake of folate and vitamin B12 also decreases metabolism of homocysteine, so that the plasma concentration increases, which can damage the endothelial membrane due to formation of thiolactone.
The obtained results confirm earlier findings where vitamin A-deficient rats were used to prove the uptake of retinyl esters into lung, liver, kidney, and plasma after inhalation thereof (Biesalski, 1996). However, long-term topical administration of high vitamin A concentrations is a well-established therapy in atrophic rhinitis, rhinitis sicca, and metaplastic changes in the nasal or ocular epithelium (Deshpande et ah, 1997 Simm, 1980). The application leads to the normalization of mucous membranes and reappearance of a normal function with no side effects. [Pg.200]

For vitamin C, plasma concentration was always about 40 gmol/liter and not significantly different between study days. There was, however, a significant difference between day 0 and day 10, respectively, versus day 20 in the plasma concentration for ot-tocopherol. [Pg.205]

PTH is secreted from the parathyroid glands in response to a low plasma concentration of ionized (free) calcium. PTH immediately causes the transfer of labile calcium stores from bone into the bloodstream. PTH increases rates of dietary calcium absorption by the intestine indirectly via the vitamin D3 system activation of enterocyte activity. Within the kidney, PTH directly stimulates calcium reabsorption and a phosphate diuresis. [Pg.755]

Compared with healthy controls, 51 patients with epilepsy taking a variety of antiepileptic drugs (mostly carbamaze-pine) had higher mean plasma concentrations of homocysteine (130). This effect, which could be related to reductions in the concentrations of folate and vitamin B6, was likely to be drug-induced, but a causative role of the underlying disease could not be excluded. Although homocysteine is an experimental convulsant and a risk factor for atherosclerosis, the clinical relevance of these findings is uncertain. [Pg.582]

FIGURE 11.8 Plasma Vitamin E concentration after oral administration of a Vitamin E solid dispersion. Key ( ) PEG-32 glyceryl laureate (Gelucffe44/14) solid dispersion and commercial product. (Adapted from Barker, S.A., Yap, S.P., Yuen, K.H., McCoy, C.P., Murphy, J.R., and Craig, D.Q.M. (2DGQ>ntrol. Rel., 91 477-488.)... [Pg.246]

Oral vitamin E, 300 mg and 600 mg daily for 2 weeks, administered to type II and IV hyperlipoproteinaemia patients increased the serum vitamin E concentration 2- fold and suppressed the normally elevated plasma lipid peroxide... [Pg.264]

As shown in the review of the homocysteine metabolism, vitamin B 2, vitamin B6, and folate are important cofactors in the metabolic pathways for homocysteine elimination, and consequently, deficiencies of these vitamins are characterized by elevated plasma concentrations of tHcy. Hyperhomocysteinemia is also frequently found in diseases such as renal failure, rheumatic and auto-immune diseases, hypothyroidism, and malignancies. Several drugs are also known to increase plasma tHcy concentrations (16-24). [Pg.178]


See other pages where Vitamin plasma concentration is mentioned: [Pg.1104]    [Pg.1104]    [Pg.385]    [Pg.22]    [Pg.379]    [Pg.484]    [Pg.572]    [Pg.197]    [Pg.226]    [Pg.995]    [Pg.268]    [Pg.270]    [Pg.30]    [Pg.4]    [Pg.857]    [Pg.879]    [Pg.163]    [Pg.156]    [Pg.299]    [Pg.300]    [Pg.190]    [Pg.206]    [Pg.261]    [Pg.469]    [Pg.173]    [Pg.69]    [Pg.763]    [Pg.858]    [Pg.880]    [Pg.1263]    [Pg.578]    [Pg.1004]    [Pg.615]    [Pg.656]    [Pg.161]    [Pg.63]    [Pg.770]    [Pg.108]    [Pg.111]   
See also in sourсe #XX -- [ Pg.65 , Pg.314 ]

See also in sourсe #XX -- [ Pg.65 , Pg.314 ]

See also in sourсe #XX -- [ Pg.65 , Pg.314 ]

See also in sourсe #XX -- [ Pg.27 , Pg.441 , Pg.475 ]




SEARCH



Ascorbic acid (vitamin plasma concentration

Plasma concentrations, of vitamin

Vitamins, concentration

© 2024 chempedia.info